Alcon (ALC) Non-Current Deffered Revenue (2009 - 2010)
Alcon (ALC) posted Non-Current Deffered Revenue of $29.0 million for Q4 2010, little changed on a QoQ basis from $29.0 million in Q4 2009, and little changed year-over-year from $29.0 million in Q4 2009.
Powered by 
Analysis
Alcon (ALC) Non-Current Deffered Revenue (2009 - 2010) Analysis & Trends
Alcon has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $29.0 million in Q4 2010.
- On a quarterly basis, Non-Current Deffered Revenue changed 0.0% year-over-year to $29.0 million in Q4 2010; TTM through Dec 2010 was $29.0 million, a 0.0% change from a year earlier, with the FY2010 full-year figure at $29.0 million, changed 0.0% from the prior year.
- Non-Current Deffered Revenue was $29.0 million for Q4 2010 at Alcon, roughly flat from $29.0 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $29.0 million in Q4 2009, with the low at $29.0 million in Q4 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | - |